Globalization of clinical trials continues

04/10/2013 | PMLive.com (U.K.)

Fewer patients from North America and Europe participated in clinical trials for drug applications submitted to the European Medicines Agency in 2011 than in 2010, according to an EMA report. Just more than 31% of clinical-trial participants were from the European Economic Area and Switzerland, 31.5% were from North America, and 37.3% were from Africa, the Middle East, the Asia-Pacific region and Central or South America. In comparison, 26.4% of clinical trial patients were not from a European or North American country in 2010.

View Full Article in:

PMLive.com (U.K.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Executive Officer
UCare Minnesota
Minneapolis, MN